Akari Therapeutics Plc

AKTX's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

AKTX Growth rates comparisons

Akari Therapeutics Plc's sales fell in the second quarter of 2025 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 8.14 %

Akari Therapeutics Plc net loss decreased from $-8 millions, to $-2 millions in second quarter of 2025,

• More on AKTX's Growth

AKTX's Valuation comparisons

Akari Therapeutics Plc
realized a net loss in trailing twelve months.

Akari Therapeutics Plc realized cash reduction of $ -0 per share in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.87.

• More on AKTX's Valuation

Total Debt (Millions $)	1
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	-
Tangible Book Value (Per Share $)	0.00

AKTX's Valuation comparisons

Akari Therapeutics Plc
realized net loss in trailing twelve months.

Akari Therapeutics Plc realized cash outflow of $ -0per share in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.87.

Akari Therapeutics Plc Price to Book Ratio is at 1794.53 higher than Industry Avg. of 39.17, and higher than S&P 500 Avg. of 0.02

• More on AKTX's Valuation

• Market Capitalization (Millions $)	45,949
• Shares Outstanding (Millions)	62,944
• Employees	12
• Revenues (TTM) (Millions $)	-
• Net Income (TTM) (Millions $)	-12
• Cash Flow (TTM) (Millions $)	-1
• Capital Exp. (TTM) (Millions $)	-
• Total Debt (Millions $)	1
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	-
• Tangible Book Value (Per Share $)	0.00

• Market Capitalization (Millions $)	45,949
• Shares Outstanding (Millions)	62,944
• Employees	12
• Revenues (TTM) (Millions $)	-
• Net Income (TTM) (Millions $)	-12
• Cash Flow (TTM) (Millions $)	-1
• Capital Exp. (TTM) (Millions $)	-

	*Ratio*
• Capital Ratio (MRQ)	0.19
• Total Debt to Equity (MRQ)	0.03
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	-
• Inventory Turnover Ratio (TTM)	-

AKTX's Profitability Comparisons

• More on AKTX's Key Ratios

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.